Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
22.2%
% of PBE's 27 holdings also in IBRN
15.8%
% of IBRN's 54 holdings also in PBE
Overlap by Weight
Sector Drift (PBE minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in PBE |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 5.2% | 4.9% | 4.9% |
|
BIOGEN IDEC INC | 5.1% | 4.7% | 4.7% |
|
PTC THERAPEUTICS INC | 3.4% | 4.7% | 3.4% |
|
CATALYST PHARMACEUTICAL PART | 3.2% | 3.3% | 3.2% |
|
INTRA-CELLULAR THERAPIES INC | 2.4% | 4.3% | 2.4% |
Position Highlights (Non-Overlapping Exposures)
PBE Overweight Relative to IBRN
|
BIO-TECHNE CORPORATION | 5.8% |
|
AMGEN INC | 5.5% |
|
REGENERON PHARMACEUTICALS | 5.2% |
|
VERTEX PHARMACEUTICALS INC | 5.1% |
|
GILEAD SCIENCES INC | 4.6% |
|
BIOMARIN PHARMACEUTICAL INC | 4.6% |
|
TG THERAPEUTICS INC | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.4% |
|
HALOZYME THERAPEUTICS INC | 3.3% |
|
BLUEPRINT MEDICINES CORP. | 3.2% |
PBE Underweight Relative to IBRN
|
CEREVEL THERAPEUTICS HOLDINGS INC | -4.8% |
|
SAREPTA THERAPEUTICS INC | -4.8% |
|
AXONICS MODULATION TECHNOLOGIES, INC | -4.7% |
 |
ARGENX SE ADR | -4.5% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -3.8% |
 |
ALKERMES PLC | -3.7% |
|
INTEGRA LIFESCIENCES HOLDING | -3.4% |
|
SUPERNUS PHARMACEUTICALS INC | -3.1% |
|
EDGEWISE THERAPEUTICS, INC. | -2.3% |
|
DYNE THERAPEUTICS INC | -2.1% |